Literature DB >> 21594669

Commentary: proteooxidotoxic process of aggregation.

Mark P Mattson1.   

Abstract

A recent editorial entitled "State of Aggregation" (Nat. Neurosci. 2011; 14:399) described the importance of establishing the structural state of pathogenic protein aggregates (Aβ, α-synuclein, huntingtin, etc.) in studies of neurodegenerative disorders. While this is a laudable goal, it is based on the assumption that the neurotoxicity depends upon a specific tertiary structure of the protein aggregates. Here, I describe evidence (not mentioned in the editorial) that suggests that it is not the protein oligomers, per se, that damage neurons. Instead, neurons are damaged by an unseen sequence(s) of chemical reactions that generate reactive oxygen species (ROS), and it is the ROS that cause both protein aggregation and neurotoxicity. The latter "proteooxidotoxicity" mechanism provides an explanation for numerous findings in the field of neurodegenerative disorders, including the inability to identify specific receptors for the pathogenic proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594669     DOI: 10.1007/s12017-011-8146-x

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  10 in total

1.  Good and bad amyloid antibodies.

Authors:  Mark P Mattson; Sic L Chan
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

Review 2.  Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity.

Authors:  M P Mattson
Journal:  Trends Neurosci       Date:  1998-02       Impact factor: 13.837

3.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

Authors:  X Huang; C S Atwood; M A Hartshorn; G Multhaup; L E Goldstein; R C Scarpa; M P Cuajungco; D N Gray; J Lim; R D Moir; R E Tanzi; A I Bush
Journal:  Biochemistry       Date:  1999-06-15       Impact factor: 3.162

4.  Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.

Authors:  Chengshan Wang; Lin Liu; Lin Zhang; Yong Peng; Feimeng Zhou
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

Review 5.  Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.

Authors:  Bharathi Shrikanth Gadad; Gabrielle B Britton; K S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation.

Authors:  R J Mark; Z Pang; J W Geddes; K Uchida; M P Mattson
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

7.  Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.

Authors:  Wen-Quan Zou; Xiangzhu Xiao; Jue Yuan; Gianfranco Puoti; Hisashi Fujioka; Xinglong Wang; Sandy Richardson; Xiaochen Zhou; Roger Zou; Shihao Li; Xiongwei Zhu; Patrick L McGeer; John McGeehan; Geoff Kneale; Diego E Rincon-Limas; Pedro Fernandez-Funez; Hyoung-gon Lee; Mark A Smith; Robert B Petersen; Jian-Ping Guo
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

8.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state.

Authors:  C J Pike; D Burdick; A J Walencewicz; C G Glabe; C W Cotman
Journal:  J Neurosci       Date:  1993-04       Impact factor: 6.167

9.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Authors:  K Hensley; J M Carney; M P Mattson; M Aksenova; M Harris; J F Wu; R A Floyd; D A Butterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

Authors:  T Tomiyama; A Shoji; K Kataoka; Y Suwa; S Asano; H Kaneko; N Endo
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

  10 in total
  3 in total

Review 1.  Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

Authors:  Milos D Ikonomovic; Zhiping Mi; Eric E Abrahamson
Journal:  Ageing Res Rev       Date:  2016-11-06       Impact factor: 10.895

2.  3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress.

Authors:  Sarah M Rothman; Nathan Herdener; Simonetta Camandola; Sarah J Texel; Mohamed R Mughal; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2011-08-19       Impact factor: 4.673

Review 3.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.